A new lab test looks for drugs that make radiation work better
Original title: A flow cytometry-based screening platform for identifying candidate radiosensitizers targeting DNA repair
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only done on cells in a lab dish.
The short version
Scientists built a lab tool to spot drugs that may help radiation kill cancer cells.
What was studied. Researchers tested up to 700 compounds on cancer cells in the lab. They used leukemia cells and lung cancer cells that had been given radiation, then checked which compounds kept the cells from fixing the damage.
What they found. Two compounds stood out in both kinds of cells. They are called 5-iodotubercidin and omipalisib. Both made cells more sensitive to radiation, and the team saw the same thing in lab grown lung cancer and glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells.
What this means, and what it doesn't
What it could mean: Nothing about care today changes because of this. It gives scientists a faster way to search for drugs that could make radiation work harder. Any drug found this way would still need years of testing first.
What it doesn't mean: This does not mean a new treatment is close. All of this was done on cells in lab dishes, not in people. It is not a cure and it is not proof that these drugs help patients. No one should ask a doctor for these compounds based on this study.
Source: bioRxiv (preprint), August 26, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.